Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism

Clinical Endocrinology

Volumn 80, Issue 4, 2014, Pages 508-515

  Lin, Ho Cheng ^a,b   Chen, Chien Liang ^a   Lin, Huey Shyan ^c   Chou, Kang Ju ^a   Fang, Hua Chang ^a   Liu, Shiuh Inn ^a   Hsu, Chih Yang ^a   Huang, Wei Chieh ^a   Huang, Chien Wei ^a   Huang, Chun K ^a   Chang, Tsu Yuan ^a   Chang, Yun Te ^a   Lee, Po Tsang ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b Kaohsiung Armed Force General Hospital   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; PARATHYROID HORMONE; PARICALCITOL;

ACUTE HEART INFARCTION; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN STEM INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DEATH; END STAGE RENAL DISEASE; FEMALE; HEART INFARCTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; TREATMENT OUTCOME;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROIDECTOMY; RENAL DIALYSIS; RISK FACTORS;

EID: 84895930466     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12333     Document Type: Article

References (39)

1. Block, G.A., Klassen, P.S., Lazarus, J.M., et al,. (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. Journal of the American Society of Nephrology, 15, 2208-2218.
2. Floege, J., Kim, J., Ireland, E., et al,. (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrology, Dialysis, Transplantation, 26, 1948-1955.
3. Ganesh, S.K., Stack, A.G., Levin, N.W., et al,. (2001) Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. Journal of the American Society of Nephrology, 12, 2131-2138.
4. Stevens, L.A., Djurdjev, O., Cardew, S., et al,. (2004) Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. Journal of the American Society of Nephrology, 15, 770-779.
5. Moe, S.M., Chertow, G.M., Coburn, J.W., et al,. (2005) Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney International, 67, 760-771.
6. Chertow, G.M., Block, G.A., Correa-Rotter, R., et al,. (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. New England Journal of Medicine, 367, 2482-2494.
7. Tominaga, Y., Matsuoka, S., &, Uno, N., (2009) Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis. World Journal of Surgery, 33, 2335-2342.
8. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney International. Supplement, S1-S130.
9. Tominaga, Y., Uchida, K., Haba, T., et al,. (2001) More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. American Journal of Kidney Diseases, 38, S168-S171.
10. Iwamoto, N., Sato, N., Nishida, M., et al,. (2012) Total parathyroidectomy improves survival of hemodialysis patients with secondary hyperparathyroidism. Journal of Nephrology, 25, 755-763.
11. Sharma, J., Raggi, P., Kutner, N., et al,. (2012) Improved long-term survival of dialysis patients after near-total parathyroidectomy. Journal of the American College of Surgeons, 214, 400-407. discussion 407-408.
12. Costa-Hong, V., Jorgetti, V., Gowdak, L.H., et al,. (2007) Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery, 142, 699-703.
13. Racki, S., Zaputovic, L., Vujicic, B., et al,. (2007) Comparison of survival between diabetic and non-diabetic patients on maintenance hemodialysis: a single-centre experience. Diabetes Research and Clinical Practice, 75, 169-175.
14. Beddhu, S., Bruns, F.J., Saul, M., et al,. (2000) A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. American Journal of Medicine, 108, 609-613.
15. Anderson, J.L., Adams, C.D., Antman, E.M., et al,. (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Journal of the American College of Cardiology, 50, e1-e157.
16. Cox, D.R., (1972) Regression models and life tables. Journal of the Royal Statistical Society, 34, 187-220.
17. Moe, S.M., &, Chen, N.X., (2008) Mechanisms of vascular calcification in chronic kidney disease. Journal of the American Society of Nephrology, 19, 213-216.
18. Block, G., &, Port, F.K., (2003) Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Seminars in Dialysis, 16, 140-147.
19. London, G.M., Guerin, A.P., Marchais, S.J., et al,. (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrology, Dialysis, Transplantation, 18, 1731-1740.
20. Bleyer, A.J., Burkart, J., Piazza, M., et al,. (2005) Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD. American Journal of Kidney Diseases, 46, 464-469.
21. Murray, T.M., Rao, L.G., Divieti, P., et al,. (2005) Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands. Endocrine Reviews, 26, 78-113.
22. Perkovic, V., Hewitson, T.D., Kelynack, K.J., et al,. (2003) Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney and Blood Pressure Research, 26, 27-33.
23. Rashid, G., Bernheim, J., Green, J., et al,. (2007) Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. American Journal of Physiology. Renal Physiology, 292, F1215-F1218.
24. van Ballegooijen, A.J., Visser, M., Cotch, M.F., et al,. (2013) Serum vitamin D and parathyroid hormone in relation to cardiac structure and function: The ICELAND-MI Substudy of AGES-Reykjavik. Journal of Clinical Endocrinology and Metabolism, 98, 2544-2552.
25. Zhang, J., Yu, X., Sun, B., et al,. (2013) Parathyroidectomy and heart rate variability in patients with stage 5 CKD. Clinical Journal of the American Society of Nephrology, 8, 1378-1387.
26. van Ballegooijen, A.J., Reinders, I., Visser, M., et al,. (2013) Parathyroid hormone and cardiovascular disease events: A systematic review and meta-analysis of prospective studies. American Heart Journal, 165, 655-664.
27. Sato, T., Tominaga, Y., Ueki, T., et al,. (2004) Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. American Journal of Kidney Diseases, 44, 481-487.
28. Gutierrez, O.M., Mannstadt, M., Isakova, T., et al,. (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. New England Journal of Medicine, 359, 584-592.
29. El-Abbadi, M.M., Pai, A.S., Leaf, E.M., et al,. (2009) Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney International, 75, 1297-1307.
30. Hu, M.C., Shi, M., Zhang, J., et al,. (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. Journal of the American Society of Nephrology, 22, 124-136.
31. Sprague, S.M., Llach, F., Amdahl, M., et al,. (2003) Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney International, 63, 1483-1490.
32. Teng, M., Wolf, M., Lowrie, E., et al,. (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. New England Journal of Medicine, 349, 446-456.
33. Goodman, W.G., &, Quarles, L.D., (2008) Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics. Kidney International, 74, 276-288.
34. Fukuda, N., Tanaka, H., Tominaga, Y., et al,. (1993) Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. The Journal of Clinical Investigation, 92, 1436-1443.
35. Gogusev, J., Duchambon, P., Hory, B., et al,. (1997) Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney International, 51, 328-336.
36. Tominaga, Y., Matsuoka, S., Sato, T., et al,. (2007) Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy. Therapeutic Apheresis and Dialysis, 11, 266-273.
37. Komaba, H., Nakanishi, S., Fujimori, A., et al,. (2010) Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism. Clinical Journal of the American Society of Nephrology, 5, 2305-2314.
38. Raggi, P., Chertow, G.M., Torres, P.U., et al,. (2011) The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrology, Dialysis, Transplantation, 26, 1327-1339.
39. Hemmelgarn, B.R., Manns, B.J., Quan, H., et al,. (2003) Adapting the Charlson Comorbidity Index for use in patients with ESRD. American Journal of Kidney Diseases, 42, 125-132.